Anke Kretz-Rommel
Chief Tech/Sci/R&D Officer at Bird Rock Bio, Inc.
Profile
Anke Kretz-Rommel is currently the Chief Technology Officer at Bird Rock Bio, Inc. Previously, she worked as a Principal at Alexion Antibody Technologies.
She holds a doctorate degree from the Swiss Federal Institute of Technology.
Anke Kretz-Rommel active positions
Companies | Position | Start |
---|---|---|
Bird Rock Bio, Inc.
Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Chief Tech/Sci/R&D Officer | 2009-08-26 |
Former positions of Anke Kretz-Rommel
Companies | Position | End |
---|---|---|
Alexion Antibody Technologies
Alexion Antibody Technologies Miscellaneous Commercial ServicesCommercial Services Alexion Antibody Technologies develops therapeutic antibodies to address multiple diseases. | Corporate Officer/Principal | - |
Training of Anke Kretz-Rommel
Swiss Federal Institute of Technology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Bird Rock Bio, Inc.
Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Health Technology |
Alexion Antibody Technologies
Alexion Antibody Technologies Miscellaneous Commercial ServicesCommercial Services Alexion Antibody Technologies develops therapeutic antibodies to address multiple diseases. | Commercial Services |
- Stock Market
- Insiders
- Anke Kretz-Rommel